Search Results 1361-1370 of 16513 for monoclonal antibody

1. Clinical trials - Oncology (Medical)

   This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...

2. Biological therapy for cancer - Care at Mayo Clinic

   Therapeutic antibodies and immunologic conjugates. In: Abeloff's Clinical Oncology. 6th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed Feb. 10 ...

3. A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers - Mayo Clinic

   [antibody to hepatitis B core antigen] antibody test) are eligible. - Patients positive for hepatitis C virus (HCV) antibody are eligible only if polymerase ...

4. A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression - Mayo Clinic

   Patients with prior hypersensitivity to monoclonal antibodies. Women who are pregnant or lactating. Patients with prior treatment with MIRV or other FRα ...

5. Debunking COVID-19 myths - Mayo Clinic

   This type of COVID-19 vaccine contains harmless S proteins. Once your immune system recognizes the S proteins, it creates antibodies and defensive white blood ...

6. A Study to Assess the Safety and Preliminary Effectiveness of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

   The purpose of this study is to evaluate the safety and preliminary effectiveness of the human anti-CD19 antibody Tafasitamab, in addition to R-CHOP ...

7. A Study of TAK-981 in Combination with Rituximab in Participants with Relapsed/Refractory (r/r) CD20-positive (CD20+) Non-Hodgkin Lymphoma (NHL) - Mayo Clinic

   iNHL (including FL of grades 1-3A and marginal zone lymphoma) refractory to rituximab or to any other anti-CD20 monoclonal antibodies ... Prior anti-CD20 antibody ...

8. Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients - Mayo Clinic

   ... antibodies against their donors are at a greater risk of rejection of their transplanted organs. Participation eligibility. Participant eligibility includes ...

9. A Study to Evaluate Intravenous TAEK-VAC-HerBy Vaccine Alone and in Combination Treatment in patients with advanced cancer - Mayo Clinic

   The primary purposes of this study are to is to assess safety and tolerability of IV administration of TVH vaccine alone and in combination with HER2 antibodies ...

10. Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age (PrE0405) - Mayo Clinic

    ... antibody AND a negative hepatitis B viral load by polymerase-chain reaction ... Patients with a negative HCV antibody are assumed to have a negative HCV viral ...